This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.83% per year. These returns cover a period from January 1, 1988 through January 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
After Golden Cross, Nicolet Bankshares (NIC)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
NICNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Enphase Energy (ENPH) Surges 12.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
Enphase Energy (ENPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
ENPHPositive Net Change TYGONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Fiverr (FVRR) Surges 5.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
Fiverr (FVRR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
FVRRPositive Net Change CARGNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Lemonade (LMND): Can Its 13.1% Jump Turn into More Strength?
by Zacks Equity Research
Lemonade (LMND) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
LMNDPositive Net Change IGICPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Zealand Pharma AS (ZLDPF): Can Its 6.8% Jump Turn into More Strength?
by Zacks Equity Research
Zealand Pharma AS (ZLDPF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ZLDPFNo Net Change DAWNNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Coeur Mining (CDE) Soars 12.5%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Coeur Mining (CDE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CDENegative Net Change UUUUPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Avino Silver (ASM): Can Its 13.5% Jump Turn into More Strength?
by Zacks Equity Research
Avino Silver (ASM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ASMPositive Net Change EXKPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Arista Networks (ANET) Moves 8.7% Higher: Will This Strength Last?
by Zacks Equity Research
Arista Networks (ANET) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ANETPositive Net Change PCORNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Dianthus Therapeutics, Inc. (DNTH) Moves 9.9% Higher: Will This Strength Last?
by Zacks Equity Research
Dianthus Therapeutics, Inc. (DNTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
DNTHPositive Net Change RPRXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Weatherford (WFRD) Soars 6.5%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Weatherford (WFRD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
WFRDNegative Net Change SUBCYPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today